Skip to main content
. 2017 Jul 17;8(47):82244–82255. doi: 10.18632/oncotarget.19284

Table 2. Genetic mutations and pathological subtypes.

Pathologic subtypes 5-WT EGFR+ KRAS+ ALK+ RET+ BRAF+ 5-MT total P-value*
All subtypes N 172 229 39 17 5 3 293 465 -
% 37.0% 49.2% 8.4% 3.7% 1.1% 0.6% 63.0% 0.3276
 LPA N 3 15 3 1 0 0 19 22
% 13.6% 68.2% 13.6% 4.5% 0.0% 0.0% 86.4%
 IMA N 12 12 10 5 0 2 29 41 < 0.0001
% 29.3% 29.3% 24.4% 12.2% 0.0% 4.9% 70.7%
 APA N 40 75 8 4 1 0 88 128 0.5203
% 31.3% 58.6% 6.3% 3.1% 0.8% 0.0% 68.8%
 PPA N 98 110 13 2 2 1 128 226 0.1923
% 43.4% 48.7% 5.8% 0.9% 0.9% 0.4% 56.6%
 MPA N 6 3 1 0 0 0 4 10 0.7471
% 60.0% 30.0% 10.0% 0.0% 0.0% 0.0% 40.0%
 SPA N 13 14 4 5 2 0 25 38 0.0207
% 34.2% 36.8% 10.5% 13.2% 5.3% 0.0% 65.8%
P-value$ 0.0282 0.0025 0.0002 0.2271 0.0127 0.0136 < 0.0001#

WT: wild-type; MT: mutant; Bold font denotes the subtype with the highest mutation rate. Red color indicates statistical significance; *compared to all subtypes; $compared to all negative groups; #comparing all pathological subtypes and all genotypes.